Home
Scholarly Works
Duration of Eculizumab therapy for a clinical...
Conference
Duration of Eculizumab therapy for a clinical response in atypical hemolytic uremic syndrome.
Authors
Mian H; Chan A; Lau K; Chan H
Name of conference
International Society of Hemostasis and Thrombosis.
Conference place
Toronto
Associated Experts
Anthony Chan
Professor, Faculty of Health Sciences
Visit profile
Hira Mian
Associate Professor, Faculty of Health Sciences
Visit profile
Contact the Experts team
Get technical help
or
Provide website feedback